Primary Recipient

VIRGINIA COMMONWEALTH UNIVERSITY

Amount

$69,453.00

Award Date

9/24/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Human granulocytic anaplasmosis (HGA; formerly human granulocytic ehrlichiosis) is an emerging and potentially fatal disease and the second most common tick-borne infection in the United States. The etiologic agent is Anaplasma phagocytophilum, an obligat

Vendors Connected to Award

Vendor	Role	Amount
Olympus America	Primary vendor	$40,083.93
Bio Rad Laboratories	Primary vendor	$29,369.06